Delivery Order SPE2DR25D7060-SPE2DR26F98WE
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Advair HFA 115-21 microgram inhalers in 12-gram quantities. The contract was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order with a ceiling value of $1,650.58. The ultimate completion date is set for July 22, 2025, with the place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams) with a ceiling value of $1,861.56. This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award utilized no set-aside designation, indicating competitive procurement....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,437.07 by the Defense Logistics Agency on November 25, 2025, for the supply of Advair HFA 115-21 mcg inhalers (12 grams). This non-competitive, firm fixed-price delivery order is scheduled for completion by November 26, 2025, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical resupply transaction supporting federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.81 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Advair HFA 115-21 mcg inhalers (12 grams). This contract was executed under a firm fixed price arrangement with no set-aside designation, indicating competitive award to this qualified vendor. The order is scheduled for ultimate completion on December 4, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,183.96 firm-fixed-price contract is for the supply of Advair HFA 115-21 MCG inhalers. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,750.71 to AmerisourceBergen Drug Corp for Advair HFA 115-21 micrograms inhaler (12 grams) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the agency's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- SPE2DR25D7060Indefinite Delivery Contract
- SPE2DR25D7060-SPE2DR26F98WEDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 19, 2025, for the supply of Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price delivery order with a ceiling value of $3,440.72 and an ultimate completion date of December 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated extensive capability in fulfilling federal procurement requirements for a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical prime contract vehicle enables the company to supply pharmaceutical commodities globally in support of military healthcare programs and other government healthcare systems through a flexible delivery order mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/18/25 |